Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Adequate Immune Reconstitution in Recipients of Unrelated Donor Hematopoietic Cell Transplants Given Rabbit Anti-Thymocyte Globulin During Conditioning.

Devon Fletcher, MD, John M. McCarty, MD, Harold M Chung, MD, Kathryn Candler, MA, Catherine H Roberts, PhD, Lisa Shickle, MS, Miriam Rabie, John Lamberta, FNP, Richard Edwards, PA-C;, MT, Amir Toor, MD

Blood (2009) 114 (22): 2234.

https://doi.org/10.1182/blood.V114.22.2234.2234

Published: 2009

Journal Articles

Aprepitant Vs. Placebo Plus Oral Ondansetron and Dexamethasone for the Prevention of Nausea and Vomiting Associated with Highly Emetogenic Preparative Regimens Prior to Hematopoietic Stem Cell Transplantation: A Prospective, Randomized Double-Blind Phase III Trial.

Patrick Stiff, MD, Mary Fox-Geiman, PharmD, Karen Kiley, MSN, NP, Nancy Porter, MSN, APN, Karen Rychlik, BA, Donna Fletcher-Gonzalez, PharmD, Amir Toor, MD, Scott E. Smith, MD, PhD, Tulio Rodriguez, MD

Blood (2009) 114 (22): 2267.

https://doi.org/10.1182/blood.V114.22.2267.2267

Published: 2009

Journal Articles

Oligoclonal T Cells Associated with Gvhd Following Allogeneic Stem Cell Transplantation Conditioned with Thymoglobulin and Reduced Intensity Total Body Irradiation.

Masoud Manjili, PhD, Catherine H Roberts, PhD, Maciej Kmieciak, PhD, Madhu S Gowda, MD, MB, BS, Andrea Ferreira-Gonzalez, PhD, Kellie Archer, PhD, Shiyu Song, MD, Harold M Chung, MD, John M. McCarty, MD, Amir Toor, MD

Blood (2009) 114 (22): 4662.

https://doi.org/10.1182/blood.V114.22.4662.4662

Published: 2009

Journal Articles

Phase III Randomized Stem Cell Mobilization Trial Comparing Standard Vs Double-Dose G-CSF Vs Standard Doses of G-CSF Plus GM-CSF in Hard to Mobilize Patients Undergoing An Autologous Hematopoietic Stem Cell Transplant (HSCT).

Elizabeth Berger, BA, Christopher Seet, MBBS, Mala Parthasarathy, MS, Tulio Rodriguez, MD, Scott E. Smith, MD, PhD, Amir Toor, MD, Mary Lee, RN, Cecilia Petrowsky, MSN, Mary Fox-Geiman, PharmD, Patrick Stiff, MD

Blood (2009) 114 (22): 3228.

https://doi.org/10.1182/blood.V114.22.3228.3228

Published: 2009

Journal Articles

A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Aaron Gerds, MD, Mary Fox-Geiman, PharmD, Kevin Dawravoo, MD, Tulio Rodriguez, MD, Amir Toor, MD, Scott Smith, MD, PhD, Donna Fletcher-Gonzales, RPh, Chindo Hicks, PhD, Patrick Stiff, MD

Blood (2007) 110 (11): 479.

https://doi.org/10.1182/blood.V110.11.479.479

Published: 2007

Journal Articles

Amelioration of Late Complications Following Unrelated Donor Bone Marrow Transplantation When Anti-Thymocyte Globulin Is Used as a Part of Conditioning.

Matthew E. Adess, MD, Patrick Stiff, MD, Tulio Rodriguez, MD, John Norton, MS, Mala Parthasarthy, BS, Mary Fox-Geiman, PharmD, Scott Smith, MD, Amir Toor, MD

Blood (2006) 108 (11): 5319.

https://doi.org/10.1182/blood.V108.11.5319.5319

Published: 2006

Journal Articles

Successful Umbilical Cord Blood Transplants in Adults Who Received a Nucleated Cell Dose ≥ 1 X 10 7 Cells/kg Processed by a Post-Thaw Non-Wash Procedure.

Patrick Stiff, MD, Michael Shane, MS, Tulio Rodriguez, MD, Jared Klein, MD, Mala Parthasarathy, John Norton, Amir Toor, MD

Blood (2005) 106 (11): 2049.

https://doi.org/10.1182/blood.V106.11.2049.2049

Published: 2005

Journal Articles

Novel Combination of Gallium Nitrate, Rituximab and Dexamethasone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma or Transformed Follicular Lymphoma.

Scott E. Smith, MD, PhD, Patrick J. Stiff, MD, Tulio Rodriguez, MD, Amir Toor, MD, Jared Klein, MD

Blood (2005) 106 (11): 4755.

https://doi.org/10.1182/blood.V106.11.4755.4755

Published: 2005

Journal Articles

Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines

Christiane Houde, Yulin Li, Lynda Song, Kevin Barton, Qing Zhang, John Godwin, Sucha Nand, Amir Toor, Serhan Alkan, N. Veronique Smadja, Hervé Avet-Loiseau, Carmen S. Lima, Lucio Miele, Lionel J. Coignet

Blood (2004) 104 (12): 3697–3704.

https://doi.org/10.1182/blood-2003-12-4114

Published: 2004

Journal Articles

Expression of Heat Shock Protein 90 and the Effects of HSP90 Inhibitor (17-AAG) in Multiple Myeloma.

Serhan Alkan, MD, Jan Duus, MD, Ismail H. Bahar, PhD, Keith F. Izban, MD, Hytham Al-Masri, MD, Tazeen Maududi, MD, Amir Toor

Blood (2004) 104 (11): 4916.

https://doi.org/10.1182/blood.V104.11.4916.4916

Published: 2004

Journal Articles

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy

Maurizio Zangari, Elias Anaissie, Bart Barlogie, Ashraf Badros, Raman Desikan, A. Viju Gopal, Christopher Morris, Amir Toor, Eric Siegel, Louis Fink, Guido Tricot

Blood (2001) 98 (5): 1614–1615.

https://doi.org/10.1182/blood.V98.5.1614

Published: 2001

Journal Articles

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

Ashraf Badros, Bart Barlogie, Christopher Morris, Raman Desikan, Sara R. Martin, Nikhil Munshi, Maurizio Zangari, Jayesh Mehta, Amir Toor, Michele Cottler-Fox, Athanasios Fassas, Elias Anaissie, Steven Schichman, Guido Tricot

Blood (2001) 97 (9): 2574–2579.

https://doi.org/10.1182/blood.V97.9.2574

Published: 2001

NARROW

Adequate Immune Reconstitution in Recipients of Unrelated Donor Hematopoietic Cell Transplants Given Rabbit Anti-Thymocyte Globulin During Conditioning.

Aprepitant Vs. Placebo Plus Oral Ondansetron and Dexamethasone for the Prevention of Nausea and Vomiting Associated with Highly Emetogenic Preparative Regimens Prior to Hematopoietic Stem Cell Transplantation: A Prospective, Randomized Double-Blind Phase III Trial.

Oligoclonal T Cells Associated with Gvhd Following Allogeneic Stem Cell Transplantation Conditioned with Thymoglobulin and Reduced Intensity Total Body Irradiation.

Phase III Randomized Stem Cell Mobilization Trial Comparing Standard Vs Double-Dose G-CSF Vs Standard Doses of G-CSF Plus GM-CSF in Hard to Mobilize Patients Undergoing An Autologous Hematopoietic Stem Cell Transplant (HSCT).

A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Amelioration of Late Complications Following Unrelated Donor Bone Marrow Transplantation When Anti-Thymocyte Globulin Is Used as a Part of Conditioning.

Successful Umbilical Cord Blood Transplants in Adults Who Received a Nucleated Cell Dose ≥ 1 X 10 7 Cells/kg Processed by a Post-Thaw Non-Wash Procedure.

Novel Combination of Gallium Nitrate, Rituximab and Dexamethasone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma or Transformed Follicular Lymphoma.

Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines

Expression of Heat Shock Protein 90 and the Effects of HSP90 Inhibitor (17-AAG) in Multiple Myeloma.

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy

High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a nonmyeloablative conditioning regimen and donor lymphocyte infusions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only